Company Executives

$MBX Management Team

Mr. P. Kent Hawryluk

President

Chief Executive Officer

Director

Age 56

Compensation $2.235M USD

Sex Male

Mr. Richard Bartram

Chief Financial Officer

Age 44

Compensation $1.154M USD

Sex Male

Dr. Salomon Azoulay

Chief Medical Officer

Age 68

Compensation $3.096M USD

Sex Male

Mr. Steven Hoerter

Executive Chairperson of the Board

Age 54

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. P. Kent Hawryluk President Chief Executive Officer Director	56	$2.235M USD	Male
Mr. Richard Bartram Chief Financial Officer	44	$1.154M USD	Male
Dr. Salomon Azoulay Chief Medical Officer	68	$3.096M USD	Male
Mr. Steven Hoerter Executive Chairperson of the Board	54	-	Male

Board of Directors

From the proxy statement filed Apr 22, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

3.8 years

from year joined

CEO also chairs the board

Steven L. Hoerter

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
P. Kent Hawryluk CEO	57	2019 7 years	Not independent	None stated	None stated	Paid as CEO
Steven L. Hoerter Board chair	55	2025 1 year	Independent	Audit Committee Science and Medicine Committee	ORIC Pharmaceuticals, Inc.	$999,986
Patrick J. Heron	55	2020 6 years	Independent	Nominating and Corporate Governance Committee Compensation Committee · Chair	Mirum Pharmaceuticals, Inc.	$220,947
Edward T. Mathers	66	2020 6 years	Independent	Nominating and Corporate Governance Committee Science and Medicine Committee	Rhythm Pharmaceuticals, Inc.	$196,190
Tiba Aynechi	50	2022 4 years	Independent	Audit Committee Compensation Committee	None stated	$200,690
Ora Pescovitz	69	2022 4 years	Independent	Science and Medicine Committee	None stated	$198,947
Steven Ryder	75	2024 2 years	Independent	None stated	None stated	$194,947
Laurie Stelzer	58	2026 0 years	Independent	Compensation Committee	Spyre Therapeutics, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$MBX Management Team

Mr. P. Kent Hawryluk

Mr. Richard Bartram

Dr. Salomon Azoulay

Mr. Steven Hoerter

Board of Directors

Related-party transactions

No related-party transactions disclosed